Skip to main navigation Skip to search Skip to main content

MCC 23221 Evaluation of Digoxin for Relapsed non-WNT, non-SHH Medulloblastoma (Phase 2 Study)

Grants and Contracts Details

Description

ABSTRACT The purpose of this study is to evaluate the efficacy of digoxin in treating relapsed non- SHH, non-WNT medulloblastoma in pediatric and young adult patients.
StatusActive
Effective start/end date10/28/2510/28/27

Funding

  • H Lee Moffitt Cancer Center and Research Institute Hospital: $2.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.